• Login
  • Register
CSI360.com
Menu
  • HOME
  • PRODUCTS
    • Orbital Atherectomy System
    • Crowns
    • Accessories
    • Asahi-Intecc Guide Wires
    • Instructions for Use
    • Order Information
  • CLINICAL
    • Peripheral Studies
    • Coronary Studies
  • CSIQ
  • PATIENTS
    • PAD Overview
    • Risk Factors
    • PAD Indicators
    • Diagnosis
    • Treatment Options
    • Questions to Ask
  • INVESTORS
    • Overview
    • Corporate Governance
    • Stock Information
    • Financial Information
    • SEC Filings
    • Calendar of Events
    • Proxy Online
    • Analyst Coverage
    • Email Alert
    • Information Request
  • ABOUT US
    • Board of Directors
    • Executive Officers
    • Newsroom
    • Careers
    • Contact
  • Home
  • :
  • About Us
  • :
  • Newsroom

News Releases

News Releases Archive >>

Wednesday, May 1, 2013
Cardiovascular Systems Reports Fiscal 2013 Third-Quarter Financial Results

Wednesday, April 24, 2013
Cardiovascular Systems to Webcast Fiscal 2013 Third-Quarter Earnings Conference Call Wednesday, May 1

Wednesday, March 20, 2013
Cardiovascular Systems Prices Public Offering of Common Stock

Tuesday, March 19, 2013
Cardiovascular Systems Announces Proposed Public Offering of Common Stock

Friday, March 15, 2013
Cardiovascular Systems Completes PMA Submission of Orbital Atherectomy System for Coronary Artery Disease Treatment

Tuesday, March 12, 2013
Cardiovascular Systems’ Orbital Atherectomy Technology Highlighted at ACC Innovations Forum



Fact Sheets

  • Corporate Fact Sheet (PDF)
  • Orbital Mechanism of Action (PDF)
  • Peripheral Arterial Disease (PDF)
  • 360° Clinical Series — (Clinical Trials FS) (PDF)
  • Lower-Limb Amputation (PDF)
  • Glossary (PDF)


Image Library


 Hi | Lo


 Hi | Lo


 Hi | Lo


 Hi | Lo


 Hi | Lo


 Hi | Lo


 Hi | Lo


 Hi | Lo






Video Library

Download Mechanism of
Action Animation

Seen Elsewhere

Amputation Prevention and Treatment
2/12/12 KSNT-TV news story

Study bolsters CSI technology to treat heart blockages
3/12/13 Star Tribune news story
  • Overview
  • Board of Directors
  • Executive Officers
  • Newsroom
  • Careers
  • Contact

Company Information

  • Corporate Fact Sheet (PDF)

Executive Bios



David L. Martin
President and
Chief Executive Officer
Cardiovascular Systems, Inc.

Executive Officers

Media Contacts

Dave Folkens
Padilla Speer Beardsley
612.455.1741
DFolkens@padillaspeer.com

Matt Sullivan
Padilla Speer Beardsley
612.455.1709
MSullivan@padillaspeer.com

  • Careers
  • Contact
  • Privacy
  • Terms of Use
  • Site Map
© 2013 Cardiovascular Systems Inc. All Rights Reserved.
  • CSI Headquarters
    651 Campus Drive
    St. Paul, MN 55112
  •  
    P:651.259.1600
      877.CSI.0360
  •  
    F:612.677.3355
    E:generalinquiries@csi360.com
  • CSI Customer Service
    P:877.274.0901
    E:generalinquiries@csi360.com

Disclosure: CSI's Orbital Atherectomy System is a percutaneous orbital atherectomy system indicated for use as therapy in patients with occlusive atherosclerotic disease in peripheral arteries and stenotic material from artificial arteriovenous dialysis fistulae. The System is contraindicated for use in coronary arteries, bypass grafts, stents, or where thrombus or dissections are present. Although the incidence of adverse events is rare, potential events that can occur with atherectomy include: pain, hypotension, CVA/TIA, death, dissection, perforation, distal embolization, thrombus formation, hematuria, abrupt or acute vessel closure, or arterial spasm.

Web Design: WebBizIdeas.com